Multi-center, randomized, double-blinded assessment of teriflunomide in extending the time to a first clinical event in radiologically isolated syndrome (RIS) The TERIS study

被引：0
|
作者：
Frenay, Christine Lebrun [1 ]
Siva, Aksel [2 ]
Kantarci, Orhun [3 ]
Azevedo, Christina [4 ]
Sormani, Maria Pia [5 ]
Pelletier, Daniel [4 ]
Okuda, Darin [6 ]
机构：
[1] Hop Louis Pasteur, Nice, France
[2] Cerrahpasa Sch Med, Istanbul, Turkey
[3] Mayo Clin, Rochester, MN USA
[4] Univ Southern Calif, Los Angeles, CA 90007 USA
[5] Univ Genoa, Genoa, Italy
[6] UT Southwestern Med Ctr, Dallas, TX USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.359
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [21] PRAISE: Prospective, Randomized, Double Blinded, Multi-Center, Clinical Study for the Evaluation of Iloprost in the Early Postoperative Period after Liver Transplantation. The Study Protocol
    Baerthel, E.
    Rauchfuss, F.
    Breternitz-Gruhne, M.
    Hoyer, H.
    Jandt, K.
    Settmacher, U.
    TRANSPLANTATION, 2012, 94 (10) : 416 - 416
  • [22] A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol
    Wu, Xiaoping
    Yan, Mingyu
    Pang, Xingxue
    Wu, Hui
    Hu, Zhigeng
    Xiao, Rui
    Pan, Jianlue
    Li, Ying
    Shi, Shengnan
    Deng, Yanping
    Li, Jiaxi
    Wang, Peili
    Chen, Keji
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [23] Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial
    M G Fehlings
    H Nakashima
    N Nagoshi
    D S L Chow
    R G Grossman
    B Kopjar
    Spinal Cord, 2016, 54 : 8 - 15
  • [24] Maintenance Therapy with an Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO/LOGOS): study protocol of a randomized double-blinded placebo-controlled multi-center Phase III Trial
    McLaughlin, P. M. J.
    Klar, M.
    Heitz, F.
    Zwimpfer, T. A.
    Dutilh, G.
    Vetter, M.
    Marth, C.
    du Bois, A.
    Schade-Brittinger, C.
    Reuss, A.
    Bommer, C.
    Kurzeder, C.
    Heinzelmann, V
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E124 - E124
  • [25] Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial
    Fehlings, M. G.
    Nakashima, H.
    Nagoshi, N.
    Chow, D. S. L.
    Grossman, R. G.
    Kopjar, B.
    SPINAL CORD, 2016, 54 (01) : 8 - 15
  • [26] Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China
    Zhen Wang
    Xin Zhang
    Yanling Qu
    Shuyang Zhang
    Yundai Chen
    Xiaoping Chen
    Xin Qi
    Peijing Liu
    Shuqin Liu
    Shan Jiang
    Ronghai Man
    Liping He
    Ling Wu
    Zhanquan Li
    Yijun Shang
    Zhaohui Qiu
    Feng Liu
    Chenhong Xu
    Chunlin Lai
    Junbo Ge
    Lipids in Health and Disease, 22
  • [27] Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China
    Wang, Zhen
    Zhang, Xin
    Qu, Yanling
    Zhang, Shuyang
    Chen, Yundai
    Chen, Xiaoping
    Qi, Xin
    Liu, Peijing
    Liu, Shuqin
    Jiang, Shan
    Man, Ronghai
    He, Liping
    Wu, Ling
    Li, Zhanquan
    Shang, Yijun
    Qiu, Zhaohui
    Liu, Feng
    Xu, Chenhong
    Lai, Chunlin
    Ge, Junbo
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [28] Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial
    Kong, Qing
    Mo, Shuming
    Wang, Wenqian
    Tang, Zihui
    Wei, Ying
    Du, Yijie
    Liu, Baojun
    Kong, Lingwen
    Lv, Yubao
    Dong, Jingcheng
    TRIALS, 2020, 21 (01)
  • [29] Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial
    Qing Kong
    Shuming Mo
    Wenqian Wang
    Zihui Tang
    Ying Wei
    Yijie Du
    Baojun Liu
    Lingwen Kong
    Yubao Lv
    Jingcheng Dong
    Trials, 21
  • [30] The PanAM study: A multi-center, double-blinded, randomized, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma
    Ridderikhof M.L.
    Lirk P.
    Schep N.W.
    Hoeberichts A.
    Goddijn W.T.
    Luitse J.S.K.
    Kemper E.M.
    Dijkgraaf M.G. W.
    Hollmann M.W.
    Goslings J.C.
    BMC Emergency Medicine, 13 (1)
12345